PFM Health Sciences’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-219,204
Closed -$41.2M 101
2018
Q4
$41.2M Buy
219,204
+94,286
+75% +$17.4M 1.1% 35
2018
Q3
$21.3M Sell
124,918
-37
-0% -$6.23K 0.31% 89
2018
Q2
$20.5M Sell
124,955
-225,119
-64% -$36.8M 0.32% 90
2018
Q1
$56.6M Sell
350,074
-42,032
-11% -$6.69M 1.15% 33
2017
Q4
$57.3M Buy
+392,106
New +$55.8M 1.36% 32
2017
Q1
Sell
-129,540
Closed -$14.9M 100
2016
Q4
$14.9M Sell
129,540
-386,085
-75% -$43M 0.42% 65
2016
Q3
$53.9M Buy
+515,625
New +$53.8M 1.58% 24
2014
Q1
Sell
-905,252
Closed -$71M 79
2013
Q4
$71M Buy
+905,252
New +$70.9M 1.43% 28
2013
Q3
Sell
-212,175
Closed -$16.1M 79
2013
Q2
$16.1M Buy
+212,175
New +$13.9M 0.33% 54

Other funds holding CME

PFM Health Sciences's CME Position: Q1 2019 in Review

PFM Health Sciences sold out of CME Group (CME) in Q1 2019, closing a stake of 219,204 shares — an estimated $41.2M sold.

PFM Health Sciences first reported a position in CME in Q2 2013 and held it in 9 quarters. The position peaked at $71M in Q4 2013. 1,001 funds tracked by Wall St. Rank hold CME as of Q1 2019.

  • PFM Health Sciences reported no remaining CME Group position as of Q1 2019 after selling out during the quarter.
  • PFM Health Sciences sold 219,204 CME Group shares in Q1 2019, an estimated $41.2M.
  • PFM Health Sciences first reported a position in CME Group in Q2 2013 and held it in 9 quarters.
  • PFM Health Sciences's CME Group position peaked at $71M in Q4 2013.
  • 1,001 funds tracked by Wall St. Rank held CME Group as of Q1 2019.

Based on PFM Health Sciences's 13F filing for Q1 2019, filed 15 May 2019.